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DWIAbstract Purpose: Our intention was to evaluate the role of combined diffusion magnetic reso-
nance imaging and spectroscopy in diagnosis and grading of brain tumors.
Materials and methods: Ninety-three included cases underwent magnetic resonance imaging (MRI)
andmagnetic resonance spectroscopy (MRS) of the brain lesion, stereotactic or open biopsies and his-
topathological examination. MRI protocol included DWI and calculated ADC values. Multivoxel
MRS spectroscopic technique (MVS) was used and all MRS metabolic parameters were obtained.
Results: High grade tumors had signiﬁcantly lower ADC values than low grade tumors (P< 0.001).
ADC values were the lowest in lymphoma (0.54 · 103 mm2/s) and the highest in craniopharyngioma
(1.9 · 103 mm2/s). MRS revealed a statistically signiﬁcant difference in CHO/NAA and CHO/Cr
ratios between low andhigh grade tumorswithP< 0.01 andP< 0.001, respectively. ThemI/Cr ratio
and presence of lactate, lipid and taurine also aided in differentiation and grading of brain tumors. The
overall MRI/MRS sensitivity and speciﬁcity were 91%, 90.5%, respectively.
Conclusion: MRS has a robust diagnostic accuracy in cases of well deﬁned high or low grade brain
neoplasms. ADC value had the ability to conﬁrm and differentiate low from high grade tumors in
many situations where there were diagnostic confusions with MRS due to borderline values.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine.Open access under CC BY-NC-ND license.1. Introduction
Brain tumors represent an important cause of morbidity and
mortality and are frequently difﬁcult to treat. Grading of intra-
cranial neoplasm is of prognostic role and has an important
inference in further management decision. Clearly, the main
850 A.E. El Sherbeny et al.purpose of progressive development of non invasive imaging
techniques, like MRI/MRS techniques, is to improve diagnos-
tic accuracy and minimize the need to more invasive diagnostic
options. For tumors where surgical resection is not the initial
therapeutic option, an accurate non-invasive diagnosis would
avoid an invasive procedure (1). Evolution in MRI procedures
has improved its value for assessing brain tumors both before
and after treatment. DWI is one of the most widely available,
practical, and robust techniques (2). It reveals the Brownian
motion of tissue water. The apparent diffusion coefﬁcient
(ADC) is principally determined by tissue cellularity, as
measured by the intracellular and extracellular volume frac-
tions (3). ADC is a helpful maneuver in discrimination
between certain types of brain tumors, like malignant lympho-
mas versus glioblastomas and metastatic tumors, and ependy-
momas versus PNETs (4). MRS contributes to metabolic
assessment of brain tumors outside that can be obtained from
anatomic imaging. Brain metabolites assessed by MRS can
characterize features of neuronal integrity (NAA), cell mem-
brane proliferation or degradation (Cho), energy metabolism
(Cr) and necrotic transformation of brain or tumor tissue
(lipid/lactate) (5). The ﬁeld of clinical applications of proton
MRS (1H MRS) in brain neoplasms is broad and includes;
classiﬁcation and grading of tumor type (6), detect subtle dif-
ferences between low grade brain tumors (7), differentiating
brain abscesses from cystic or necrotic tumors, evaluating
the response of brain tumors to different therapeutic options
and ability to differentiate between tumor recurrence and radi-
ation necrosis (8).
2. Materials and methods
One hundred and forty-ﬁve consecutive cases were recruited.
All patients underwent proper history taking, MRI and
MRS of the brain lesion, stereotactic or open biopsy and his-
topathological examination of the tumor as a gold standard
method to provide accurate diagnosis.
2.1. MRI protocol
MRI 1.5-Tesla unit was used for all patients at the radiodiag-
nosis department at Tanta University. Scan parameters used
were; T1 weighted images (T1 WI) with short TR 400–
500 ms. and short TE 15–25 ms. T2 weighted spin echo images
(T2 WI) with long TR 3500–5000 ms and long TE 80–100 ms,
Fluid Attenuation Inversion Recovery (FLAIR) images with
TR 2000–3000 ms. TE 15–25 ms, inversion time TI 700 ms
and gadolinium enhanced T1 images. In addition, diffusion
weighted images (DWI) were obtained by using an axial echo
– planar SE sequence (6000/92 s) [TR/TE], one average, 5 mm
section thickness. DW images and ADC maps were acquired
by using b values of 0, 500 and 1000 s/mm2 applied in the X,
Y and Z directions. Tumoral core and peri-tumoral high signal
intensity areas were sampled manually, while preferably avoid-
ing cystic and necrotic areas. Standard mean ADC values were
calculated automatically and expressed in 10–3 mm2/s. In all
cases, normal, tumoral and peritumoral regions were deﬁned
on the bases of the following imaging features: (1) Normal tis-
sue; an area containing no enhancement and normal signal
intensity on T2 WIs and)FLAIR(, (2) Tumoral area; a region
containing a well-deﬁned solid portion, contrast enhancementor abnormal signal intensity on T2 WIs and (FLAIR), (3)
Peritumoral area, a region containing no enhancement and
shows high signal intensity on T2 WIs and (FLAIR) and
peri-lesional edema.
2.2. MRS protocol
All cases were evaluated by multivoxel spectroscopic technique
(MVS). In MVS, we applied 16 · 16 grid avoiding areas that
show hemorrhage or necrosis and avoiding contamination
from nearby bone or CSF spaces. From this grid only 9 or 8
separate voxels (voxel size, 15 · 15 · 10 mm) were individually
placed in the area of the tumor, peritumoral area and contra-
lateral normal brain area. We used point resolved spectroscopy
(PRESS) with parameters TR/TE 1000/144 and 1500/35. Both
long and short TE (144 and 35 ms) were used. Long TE was
used to visualize peak intensity of CHO, Cr, Mi and NAA,
to obtain CHO/NAA CHO/Cr and mI/Cr ratios and to deter-
mine the presence of Lactate (Lac). Short TE was mainly used
to illustrate Lipid (Lip) peak. In addition, alanine and taurine
levels were obtained from intralesional parts.
2.3. Biopsy and histopathology methods
Open or stereotactic biopsies were obtained by an expert neu-
rosurgeon. In our study histopathology was done for all cases
except in 8 cases of metastasis and one case of lymphoma
which were unﬁt for surgical procedure with a known history
of primary tumor. Thirty-eight cases underwent open biopsy
and 46 cases underwent stereotactic biopsy. Formalin-ﬁxed
parafﬁn-embedded tissue sections were used. The sections were
then evaluated for the presence of nuclear pleomorphism,
mitotic ﬁgures, micro vascular proliferation, and necrosis.
Grading and typing of tumors was based on the World Health
Organization (WHO) criteria. According to WHO, tumors
were classiﬁed into low grade tumors (I–II) and high grade
tumors (III–IV).
2.4. Data analysis
Statistical data analysis was performed, using statistical pack-
age for social science (SPSS), version 16. For interpretation of
results, P value of 60.05 was considered signiﬁcant.
3. Results
The 93 patients who proved histopathologically to have brain
tumors, included 51 males (55%), 42 females (45%) with their
ages ranging from 10 to 73 years. The most common age of
incidence of brain tumor in our patients was >50 years
(40.8%).
3.1. According to histopathological ﬁndings
The primary tumor of origin represented 84%, while meta-
static brain tumors in 16% cases. Out of 93 included patients,
34 (31%) cases had low grade tumors (Grades I, II), while 64
cases (69%) had high grade tumors (Grades III and IV). Sixty
(64.5%) cases were glial tumor in origin, while 33 cases
(35.5%) were non glial tumor in origin. Glioblastoma
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glial tumors), while metastasis was the most common of non
glial tumors (45.4%). According to WHO classiﬁcation (9),
low grade tumors are grades I, II and high grade tumors are
grades III and IV, (Table 1).
3.2. According to MRI ﬁndings
Intra axial tumors represented 82 cases (88.2%) while extra
axial tumors were 11 (11.2%) cases. The most common intra
axial tumor in our patients was glioblastoma multiformis
(GBM) (32% of all intra axial tumors), while the most com-
mon extra axial tumor was meningioma (45.4% of all extra
axial tumors). The diagnosis is based on signal intensity, heter-
ogenousity, necrosis, hemorrhage, edema and mass effect,
(Table 1). The DWI calculated ADC values from tumoral
areas were the lowest in lymphoma (0.54 + 0.18 · 103 mm2/
s) and the highest in craniopharyngioma (1.9 · 103 mm2/s).
There was highly statistically difference between high and
low grade tumors regarding the calculated ADC values (P
value < 0.001). High grade malignant tumors had signiﬁcantly
lower ADC values than those of low grade tumors, (Fig. 1).
No signiﬁcant difference was recorded between ADC values
of different types of tumor of the same grade.
3.2.1. According to MRS ﬁndings
The calculated CHO/NAA and CHO/Cr ratios showed signif-
icant difference between low and high grade tumors with no
signiﬁcant difference between different tumors of the same
grade, (Fig. 2). There was signiﬁcant difference in CHO/
NAA mean values between low and high grade tumors with
P value (<0.01).
Similarly, there was highly signiﬁcant difference in CHO/Cr
mean values between low and high grade tumors with P value
(<0.001) (Fig. 2). Myoinositol which is considered as a glial
marker also added additional diagnostic value to MRS. Our
ﬁndings showed that Myoinositol was higher in patients with
low grade glioma and lower in those who had high grade gli-
oma. Calculated mI/Cr ratio was higher in patients with low-
grade astrocytoma, ependymoma, oligodendroglioma and
lower in patients with anaplastic astrocytoma, choroid plexus
carcinoma and GBM, (Fig. 3).
The presence of lipids and lactate was also aided in grading
of brain tumors. Both long and short TE (144 and 35 ms)
respectively were used to evaluate the presence of lactate andTable 1 Classiﬁcation of brain tumors of included 93 cases accord
High grade tumors N (%)
1:GBM 32 (34.4)
2:Metastases 15 (16.1)
3:Anaplastic astrocytoma 5 (5.4)
4:Lymphoma 4 (4.3)
5:Medulloblastoma 3 (3.2)
6:Gliomatosis cerebri 2 (2.2)
7:Germinoma 2 (2.2)
8:Choroid plexus carcinoma 1 (1.1)
Total 64 (69%)
Glial in origin 60 (64.5%)
Intra-axial tumors 82 (88.2%)lipid. The lactate peak was well demonstrated on long TE
while the lip peak was much more evident on short TE. Low
grade gliomas showed absent or low lactate and lipid. With
increasing malignancy, there was an increase in lactate and
lipid peaks with a signiﬁcant difference for lipid between low
and high grade tumors (Fig. 4). All the cases of GBM, medul-
loblastoma, germinoma, lymphoma, choroid plexus carcinoma
and metastases show high lipid/lactate peaks. Craniopharyngi-
oma is a benign tumor that showed high lipid lactate due to its
cholesterol content (ﬁg. 5).
In the present study, additional MRS diagnostic value was
also found in the differentiation between primary high grade
brain tumors (GBM and lymphoma) and metastatic tumors
using the calculated CHO/NAA and CHO/Cr ratios from per-
ilesional voxels. The primary tumors showed increased ratios
(more than 1.2) which denote peri-lesional inﬁltration, while
metastatic tumors showed normal ratios denoting peri-lesional
edema. Moreover, MRS showed a signiﬁcant role in differen-
tiation between medulloblastoma and ependymoma by the
presence of taurine (at 3.4 ppm) which is a speciﬁc metabolite
for medulloblastoma (Table 2).
MRS has also aided in the differentiation between pituitary
adenoma and craniopharyngioma, as pituitary adenoma
showed high choline while craniopharyngioma showed high
lipid, lactate (cholesterol content) with absence of other metab-
olites. In the present study MRS showed the ability to conﬁrm
the diagnosis of Meningioma cases by the presence of alanine
(at 1.4 ppm) which is a speciﬁc metabolite for meningioma.
MRS was insigniﬁcant in differentiation between meningioma
and acoustic neuroma because both tumors have same spectro-
scopic pictures (Table 3).
MRS shows ability to differentiate between tumor recur-
rence and radiation necrosis, tumor recurrence showed high
Cho/Cr ratio, and Cho/NAA, while radiation necrosis showed
high lipid/lactate levels with normal ratios of Cho/Cr ratio,
and Cho/NAA. The overall diagnostic accuracy of combined
MRI/MRS in 93 cases in whom histopathology were obtained
was 91% with considerable high sensitivity (91%) and speciﬁc-
ity (90.5%) (Figs. 6–8).
In few cases MRS was not able to accurately diagnose the
brain tumor type or grade. One case of gliomatosis cerebri was
initially diagnosed as low grade glioma, 2 cases of astrocytoma
grade II were diagnosed as anaplastic astrocytoma, 2 cases of
anaplastic astrocytoma were diagnosed as GBM, one case
of ependymoma was diagnosed as low grade astrocytoma
and 2 cases of glioblastoma multiformis were diagnosed asing to WHO classiﬁcation (9).
Low grade tumors N (%)
1:Low grade astrocytoma (II) 16 (17.2)
4:Meningioma 5 (5.4)
2:Oligodendroglioma 2 (2.2)
3:Ependymoma 2 (2.2)
6:Pituitary adenoma 2 (2.2)
5: Acoustic neuroma 1(1.1)
7:Craniopharyngioma 1(1.1)
–
Total 29 (31%)
Non glial in origin 33 (35.5%)
Extra-axial tumors 11 (11.8%)
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Fig. 1 Comparison of ADC individual values between low and high grade tumors.
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Fig. 4 Showing the percentages of positive MRS lipid/lactate in
low and high grade tumors. The tumors represented in the graph
are those with more than 2 cases.
852 A.E. El Sherbeny et al.metastasis. These cases were diagnosed histopathologically. In
addition, MRS has a limited role in brain tumors with massive
hemorrhage as massive hemorrhage interferes with spectros-
copy results. Finally, in the present study we excluded 52 cases
of non neoplastic tumor like conditions. Clinical presentation,
combined MRI/MRS, and therapeutic response of these cases
were concordant to be non neoplastic. Most of these caseswere radiation necrosis, brain infarction, tumefactive MS,
brain abscess and brain gliosis (Figs. 9 and 10).
4. Discussion
During the proposal of this study, it was clear to us that
MRS alone may have inadequate speciﬁcity in diagnosing of
C: Perilesional voxel (TE 144)B: Intralesional voxel (TE 144)A: MRS voxels (TE 144)
D: ADC map 
Fig. 5 Glioblastoma multiformis, male patient, 61 years presented with headache. MRI (A) showed right parietal intraaxial lesion
surrounded by grade II vasogenic edema with marginal enhancement of non uniform thickness after IV contrast. DWI shows restricted
diffusion with central area of free diffusion, calculated ADC value = 0.5 · 10–3 mm2 s. MRS: Intra-lesional and perilesional voxels (B, C)
shows marked › CHO, marked ﬂ of Cr and NAA,with ratios of CHO/NAA= 6.2, CHO/Cr = 5.8, › lipid/lactate also are seen.
Table 2 Role of MRS/ADC in differentiation between speciﬁc tumor types.
Tumor type Mean ADC value Mean CHO/NAA Mean CHO/Cr L/L Myoinstol Taurine
1- Medulloblastoma – 5 .3 5 .2 +ve absent +ve
2- Ependymoma – 2.2 2.3 ve elevated ve
Tumor type Mean ADC value Mean CHO/NAA Mean CHO/Cr Mean L/L – –
1- Glioblastoma multiformis 0.8 5.6 5.7 +ve – –
2- Lymphoma 0.55 3.5 4.5 +ve – –
3- Metastasis – 0.8 0.9 – –
Table 3 Role of MRS in differentiation between extra-axial brain tumors.
Tumor type N CHO Cr NAA L/L Alanine
1- Meningioma 5 › ﬂ ﬂ +ve (1) +ve
ve (4)
2- Acoustic neuroma 1 › ﬂ ﬂ +ve (1) +ve
Type of tumor N CHO Cr NAA L/L –
1- Pituitary adenoma 2 › ﬂ ﬂ ve –
2- Craniopharyngioma 1 Absent Absent Absent +ve High –
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854 A.E. El Sherbeny et al.different brain lesions despite being highly speciﬁc in certain
conditions. As well it is unusual in clinical practice that
MRS is requested alone, but rather requested with or after
MRI as a complementary tool when diagnosis is still doubtful.
Therefore the present study was designed to outline the possi-
ble diagnostic role of combined MRI/MRS in classiﬁcation
and management of different types of brain tumors. Most of
the brain tumors in the present study were glial in origin
(64.5%). Shih et al. (10) mentioned that the glial cell tumors
are the most common primary central nervous system neo-
plasm. In agreement with Doolittle (11), the most common
glial tumor in our study was GBM (53.3% of all glial tumors).
Diffusion WI was used as indicator of tumor grade by pro-
viding information about tumor cellularity. In the present
work, there was statistically signiﬁcant difference between
mean calculated ADC values of low and high grade tumors
with no signiﬁcant difference tumor of the same grade. Subse-
quently, the mean calculated ADC values were considerably
effective in grading of malignant tumors. Bulakbasi et al.B: MRS voxelsA: Axial T1 (post contrast) 
D: ADC map
Fig. 6 Lymphoma; male patient aged 68 years, contrast MRI (A) s
lesion intra axial SOL in right parietal and bilateral frontal regions, wi
WI shows restricted diffusion with calculated ADC value (D) = 0.4 ·
CHO, reduction of Cr and NAA,with ratios of CHO/NAA= 5.2, CH(12) and Vincentelli et al. (13) agreed with our ﬁndings and
explained that the greater the density of structures hindering
water mobility, the lower the ADC and that the differentiation
of pathologic subtypes having the same grade by ADC value is
more problematic than grading ratios. Moreover, ADC value
could characterize lymphoma from GBM. The ADC value
of lymphoma (0.54 ± 0.18 · 10–33 mm2 s) was lower than that
of GBM (0.9 ± 0.047 · 10–33 mm2 s). This can be explained by
higher cellularity of lymphoma than GBM (due to presence of
necrosis). This is in agreement with Toh et al. (14) who men-
tioned that the ADC is useful in the distinction between lym-
phoma and GBM inﬁltrating the corpus callosum. In
addition, combination of DWI and ADC value could differen-
tiate between GBM and metastatic tumors by the presence of
tumor inﬁltration in GBM and perilesional vasogenic edema in
metastasis. Lee et al. (15) and Pavlisa et al. (16) agreed with
this outcome and veriﬁed that DWI showed free diffusion in
edema contrary to restriction diffusion in areas of densely
packed tumor cells. ADC value is low in tumoral inﬁltrationC: Intralesional (TE 144) (TE 144)
hows multiple well deﬁned periventricular and deep white matter
th moderate homogenous enhancement after IV contrast, diffusion
10–3 mm2 s. MRS of intra-lesional voxel (B, C) shows elevation of
O/Cr = 5.1 short TE shows moderate elevation of lipid/lactate.
C: ADC map B: Intralesional voxel (TE 35)A: MRS voxels (TE 144)
Fig. 7 Medulloblastoma; male, 20 yrs, presented with headache and ataxia. MRI (A) shows right cerebellar intra axial SOL displaying
hypo intense signal in T1 WI, with mild enhancement after IV contrast, .The lesion is surrounded by mild vasogenic edema. DWI shows
restricted diffusion, ADC value = 0.6 · 10–3 mm2 s. MRS intra-lesional voxel shows marked › CHO, marked ﬂ Cr and NAA, CHO/
NAA= 6.5, CHO/Cr = 6.2, with › of lipid/lactate. Taurine is present at 3.4 ppm (B).
C: ADC map B: Intralesional voxel (TE 35)A: MRS voxels (TE 144)
Fig. 8 Meningioma; female, 40 years presented with epilepsy. MRI (A) shows left temporal extra axial SOL displaying iso-intense signal
in T1 with marked homogenous enhancement after IV contrast, no restricted diffusion could be detected, calculated ADC value
(C) = 1.7 · 10–3 mm2 s. MRS shows mild › of CHO, with mild ﬂ of NAA and Cr, CHO/NAA= 1.9, CHO/Cr = 1.8. Short TE shows ›
level of alanine (B), (speciﬁc for meningioma), with mild › of lipid/lactate.
Diagnostic yield of combined MRS and DWI in intracranial neoplasms 855and high in peritumoral edema. Further, in concordant with
Yamasaki et al. (4), the ADC value of craniopharyngioma
(1.9 · 10–33 mm2 s) was higher than that of pituitary adenoma
(1.7 ± 0.2 · 10–33 mm2 s).
In the present study we used MVS as it has the ability to
survey the whole neoplastic area, peritumoral area for inﬁltra-
tion and edema. Both long and short TE (144 and 35 ms) were
used. The spectra of long TE can easily detect and quantify
peaks of NAA, CHO and Cr (17). In general, MRS of intracra-
nial neoplasms typically shows elevated choline and reduced
NAA and creatine. McKnight et al. (18) have shown that the
Choline/NAA and Choline/Cr ratios are in parallel with cell
density, proliferative index and the ratio of proliferation to cell
death. As well, both ratios increase with an increase in grade of
malignancy. In our cohort of patients, the signiﬁcance of
CHO/NAA and CHO/Cr ratios in diagnosis and grading ofbrain tumor has been demonstrated. CHO/Cr ratio was more
signiﬁcant (P< 0.001) than CHO/NAA ratio (P< 0.01). Fur-
ther, GBM had higher CHO/NAA and CHO/Cr ratios than
anaplastic astrocytoma. Brandao et al. (19) similarly reported
a statistically signiﬁcant higher Cho/Cr, Cho/NAA in high
grade gliomas and added that Cho/Cr ratio is speciﬁcally use-
ful in grading of brain gliomas. By contrast, Howe et al. (20)
stated that Cho/Cr is elevated in grade III more than Grade
IV gliomas because of prominent necrosis that is usually pres-
ent in grade IV gliomas. This disagreement may be explained
by that we intentionally choose and placed the voxels in the
most enhanced solid parts away from necrotic areas. Addi-
tional importance of MRS parameters in discrimination of
brain neoplasms was found. MRS could distinguish between
GBM and metastasis by calculating perilesional CHO/NAA
and CHO/Cr ratios. GBM showed high CHO/NAA and
C: ADC map B: Intralesional voxel (TE 35)A: MRS voxels (TE 144)
Fig. 9 Craniopharyngioma; male, 19 years presented with visual impairment. MRI (A) shows sellar and suprasellar lesion with mixed
cystic and solid component with mild homogenous enhancement of the solid part after IV contrast, no restricted diffusion could be
detected. ADC value (C) = 1.9 · 10–33 mm2 s. MRS (B) shows marked › of lipid/lactate with absent other metabolites.
C: Intralesional voxel (TE 35)B: Intralesional voxel (TE144 )A: MRS voxels (TE 144)
D: ADC map 
Fig. 10 Choroid plexus carcinoma; one month old infant presented with a large head. MRI (A) shows Intra ventricular SOL occupying
the lateral ventricle with marked homogenous enhancement after IV contrast. Diffusion WI shows restricted diffusion with calculated
ADC value (D) = 0.7 · 10–3 mm2 s. MRS intra-lesional voxel (B, C) shows marked elevation of CHO, marked reduction of Cr and
NAA,with ratios of CHO/NAA= 4.4, CHO/Cr = 3.8 short TE shows marked elevation of lipid/lactate.
856 A.E. El Sherbeny et al.CHO/Cr ratios denoting tumor inﬁltration while metastasis
showed normal CHO/NAA and CHO/Cr ratios denotingperi-lesional vasogenic edema. Brandao et al. (19) declared
comparable conclusions. Similar to ﬁndings of Castillo et al.
Diagnostic yield of combined MRS and DWI in intracranial neoplasms 857(21) and Howe et al. (20), the mI/Cr ratios showed an inverse
relationship with tumor grade (higher in patients with low-
grade astrocytoma, ependymoma, oligodendroglioma and
lower in patients with anaplastic astrocytoma, choroid plexus
carcinoma and GBM). Myoinositol is a glial marker because
it is primarily synthesized in glial cells, almost only in astro-
cytes. The presence of lactate and lipids denotes high grade
tumors. With increasing malignancy, tumors showed increas-
ing lactate and lipid peaks with signiﬁcant difference for lipid
and lactate between low and high grade tumors. Bulik et al.
(22) accomplished a similar result. According to Shih et al.
(10), the peak of lactate is barely seen in normal brain. Lactic
acid is a product of anaerobic glycolysis so its concentration
increases under anaerobic metabolism in malignant tumors.
Van der Graaf (23) added that lipid peak can be seen when
there is cellular membrane breakdown or necrosis such as in
metastases or primary malignant tumors. In agreement with
Vuori et al. (24), the spectroscopic ﬁndings of the present work
could differentiate between astrocytoma grade II and oligo-
dendroglioma. Oligodendroglioma showed prominent eleva-
tion of CHO and Cr, while grade II astrocytoma showed a
mild increase in CHO and a decrease in Cr. Furthermore,
MVS has a signiﬁcant role in differentiation between cranio-
pharyngioma and pituitary adenoma. Pituitary adenoma was
seen in two cases, that showed prominent CHO peak with
low levels of NAA and creatine while craniopharyngioma
showed absent CHO, NAA, Cr with dominant lipid/lactate
peak (high cholesterol content). Faghih et al. (25) have shown
analogous ﬁndings. On the other hand, quite different results
have been reported by Sutton et al. (26) They stated that all
the pituitary adenomas showed prominent peak of choline
with no other metabolites. The presence of NAA and Cr with
dominant CHO peak in our results may be explained by con-
tamination with neural tissue. For the 5 cases of meningioma,
MRS showed unique presence of alanine in addition to
increased choline, reduced creatine and NAA. This is in accor-
dance with other authors (23,27) who declared that the most
characteristic feature of meningiomas is the presence of ala-
nine. One case of acoustic neuronal was included in our study.
MRS showed a similar spectroscopic picture to that of menin-
gioma cases. However, there was elevated lipid and lactate
which may be related to the presence of cystic component of
the tumor. Brandao et al. (19) explained that lipids do not nec-
essarily represent necrosis but may be related to the presence of
cysts. MRS was insigniﬁcant in differentiating between menin-
gioma and acoustic neuroma due to similar spectroscopic pic-
ture of both tumors. The MRS of 3 cases of cerebellar
medulloblastoma characteristically showed the presence of
taurine which is the most speciﬁc metabolite for diagnosis of
medulloblastoma in addition to elevated Cho/Cr and Cho/
NAA ratios, and presence of lipid and lactate. Spectroscopy
was signiﬁcant in differentiation between medulloblastoma
and ependymoma. Medulloblastoma cases showed a marked
presence of taurine, lipid and lactate which are absent in epe-
nymoma. As well, there were higher CHO/NAA and CHO/Cr
ratios in medulloblastoma cases than in ependymoma cases.
On the other hand myo instol is elevated in ependymoma
and absent in medulloblastoma. This is in accordance with
Majos et al. (28) who veriﬁed that the elevation of the Cho
peak, Cho/Cr and Cho/NAA ratios in medulloblastomas is
linked to the high cell density and reﬂecting its malignant
nature.Comparative results of combined MRI/MRS and histopa-
thological established that the diagnostic accuracy of com-
bined MRI/MRS was 91%, with high sensitivity (91%) and
speciﬁcity (90.5%). Comparable ﬁndings were mentioned by
other investigators (29,30). Majo´s et al. (31) also elucidated
that brain tumor classiﬁcation using spectroscopy was accurate
in 105 of 112 cases, with an accuracy of 94%. Expectedly, eight
out of 93 cases were mis-graded or mis-diagnosed by MRS.
The spectroscopic overlapping is well known and has been
documented by many authors. Brandao et al. (19) showed
some overlap between grades II and III astrocytomas also
between GBM and metastasis. The overlap between GBM
and metastasis was explained that the high MRS parameters
in the peritumoral region surrounding a GBM may not be
demonstrated in the spectrum, as these changes are related
to a number of tumor cells that have inﬁltrated the peritumoral
area. If no elevation of the CHO peak is seen in the peritumor-
al area, a high grade primary tumor cannot be ruled out.
Although not directly tested, MRS potentially plays an impor-
tant role in biopsy guidance to recognize regions of high met-
abolic activity. This is especially important when
histopathology is not helpful due to sampling errors or only
a few small tissue samples were obtained by stereotactic
biopsy. Chernov et al. (32) revealed that compared to MRI-
guided technique they have described an increase in the diag-
nostic yields of MRS-supported stereotactic brain biopsies
from 90% to 100%. Finally, this study showed that MRS
had a valuable role in differentiation between tumor recur-
rence and radiation necrosis. Smith et al. (33) demonstrated
that the distinction between recurrent tumor and radiation
necrosis using the Cho/NAA ratio could be made with
85%sensitivity and 69% speciﬁcity.
In conclusion, combined calculated ADC values from DWI
and MRS techniques, have yielded a signiﬁcant synergetic
potency in diagnosis of intracranial neoplasms. MRS has
robust diagnostic accuracy in cases of well deﬁned high or
low grad brain neoplasms. ADC value had the ability to con-
ﬁrm and differentiate low from high grade tumors in many sit-
uations where there were diagnostic confusions with MRS due
to borderline values. To a signiﬁcant extent, our inferences can
be reﬂected on clinical practice and decision making, as it may
obviate or at least minimize the need for more invasive diag-
nostic techniques. Other potential beneﬁts include, measuring
treatment effect, guidance of brain biopsy, differentiation
between radiation necrosis and tumor recurrence, follow up
of brain tumors and differentiation between neoplastic and
non neoplastic tumor like conditions.
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